NIH-funded research NIH-funded research

Targeting brain circuits to help people with schizophrenia quit smoking

Official title: Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia

Funded at Vanderbilt University Medical Center · NIH-11014359 · Data updated 2026-11-12

This study is looking at how certain brain areas related to nicotine cravings can be helped with a special treatment called brain stimulation, to make it easier for people with schizophrenia to quit smoking.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$185,544
NIH project number5K23DA059690-02
Project IDNIH-11014359 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with schizophrenia who are also dependent on nicotine and seeking help to quit smoking.

Less likely to help

Patients who do not have schizophrenia or those who are not nicotine dependent may not benefit from this research.

What this research studies

This research investigates how specific brain circuits related to nicotine dependence in individuals with schizophrenia can be targeted to help reduce cravings for cigarettes. Using advanced techniques like repetitive transcranial magnetic stimulation (rTMS), the study aims to modify the Default Mode Network (DMN), a brain circuit identified as crucial for nicotine craving. By comparing the effects of different interventions on this network, the research seeks to develop more effective smoking cessation strategies tailored for those with schizophrenia, who often struggle with existing treatments. Participants may experience a novel approach to managing their cravings through brain stimulation techniques.

Why it matters

Potential benefit: If successful, this research could lead to more effective smoking cessation methods specifically designed for individuals with schizophrenia, potentially improving their overall health and life expectancy.

How similar studies have gone: Previous research has shown promise in using brain stimulation techniques for addiction treatment, suggesting that this approach may be effective, though it is specifically tailored for schizophrenia in this case.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Ward, Heather Burrell — Vanderbilt University Medical Center
  • Study coordinator: Ward, Heather Burrell

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.